Dániel Fekete, Richárd Ferdinánd Tóth, Zsombor Kristóf Nagy, Thorsten Cech, Lukas Ries, Edina Szabó
{"title":"Continuous twin-screw wet granulation without adding granulation liquid.","authors":"Dániel Fekete, Richárd Ferdinánd Tóth, Zsombor Kristóf Nagy, Thorsten Cech, Lukas Ries, Edina Szabó","doi":"10.1016/j.ejps.2025.107295","DOIUrl":null,"url":null,"abstract":"<p><p>Granulation is a major focus of pharmaceutical R&D, as a key step in the development of solid pharmaceuticals. In parallel, the spread of continuous integrated powder-to-tablet production lines is also underway. In this research, a new wet granulation method has been investigated in terms of operation and scalability in a fully continuous powder-to-tablet line. The new wet granulation technique requires no addition of granulation liquid to the powder blend; thus, requires only minimal cooling after granulation, providing a more energy-efficient continuous integrated system for the pharmaceutical industry. This can be achieved by adding an excipient with a monograph and a high daily intake, potassium sodium tartrate tetrahydrate (PST), to the starting powder mixture. PST contains water of crystallization which is released by temperature, forming an in-situ granulation liquid during the process. This wet granulation-based technology produced granules with excellent flowability and immediate-release tablets exceeding 100 N breaking force and 1.5 MPa tensile strength. The continuous setup enabled easy scale-up from 0.5 to 10 kg/h using the same equipment and process parameters.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107295"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejps.2025.107295","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Granulation is a major focus of pharmaceutical R&D, as a key step in the development of solid pharmaceuticals. In parallel, the spread of continuous integrated powder-to-tablet production lines is also underway. In this research, a new wet granulation method has been investigated in terms of operation and scalability in a fully continuous powder-to-tablet line. The new wet granulation technique requires no addition of granulation liquid to the powder blend; thus, requires only minimal cooling after granulation, providing a more energy-efficient continuous integrated system for the pharmaceutical industry. This can be achieved by adding an excipient with a monograph and a high daily intake, potassium sodium tartrate tetrahydrate (PST), to the starting powder mixture. PST contains water of crystallization which is released by temperature, forming an in-situ granulation liquid during the process. This wet granulation-based technology produced granules with excellent flowability and immediate-release tablets exceeding 100 N breaking force and 1.5 MPa tensile strength. The continuous setup enabled easy scale-up from 0.5 to 10 kg/h using the same equipment and process parameters.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.